GE offers off-the-shelf manufacturing plants; Valeant, Medicis combine operations;

> GE Healthcare is now selling what it calls KUBio, an off-the-shelf, 1,200-square-meter modular factory that can be quickly erected and ready to manufacture. Story

> GeneTex, the U.S. antibody producer, says it will make a new antibody against HIF1a (hypoxia-inducible factor 1alpha) that is more stable than many on the market. Item

> Under new rules in Denmark, drug manufacturers' authorization to do business will not have to be updated but will be considered valid unless regulators take steps to change them. Story

> Valeant Pharmaceuticals ($VRX) is buying dermatology specialist Medicis Pharmaceuticals for $2.6 billion. Story

And Finally... More than 50 years after its morning sickness drug Thalidomide was banned because it causes deformities in children whose mothers took it, the German drugmaker Grunenthal has apologized for its effects. Story

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.